Cardiac sarcoidosis

Journal of Internal Medicine

Volumn 280, Issue 1, 2016, Pages 129-131

  Kandolin, R ^a   Lehtonen, J ^a   Kupari, M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; TROPONIN T;

ATRIOVENTRICULAR BLOCK; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; DEFIBRILLATOR; EDITORIAL; GRANULOMATOUS INFLAMMATION; HEART ARREST; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPEAT PROCEDURE; SARCOIDOSIS; WHOLE BODY PET;

EID: 84975132911     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12498     Document Type: Editorial

References (19)

1. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 2011; 4: 303–9.
2. Nery PB, Beanlands RS, Nair GM et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol 2014; 25: 875–81.
3. Kandolin R, Lehtonen J, Airaksinen J et al. Cardiac sarcoidosis: epidemiology, characteristics and outcome over 25 years in a nationwide study. Circulation 2015; 131: 624–32.
4. Tung R, Bauer B, Schelbert H et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. Heart Rhythm 2015; 12: 2488–98.
5. Nery PB, Mc Ardle BA, Redpath CJ et al. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol 2014; 37: 364–74.
6. Youssef G, Beanlands RS, Birnie DH et al. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart 2011; 97: 2078–87.
7. Patel MR, Cawley PJ, Heitner JF et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120: 1969–77.
8. Birnie DH, Sauer WH, Bogun F et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014; 11: 1305–23.
9. Simonen P, Lehtonen J, Kandolin R, et al. 18F-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis. Am J Cardiol 2015; 116: 1581–5.
10. Kandolin R, Lehtonen J, Graner M et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011; 270: 461–8.
11. Uemura A, Morimoto S, Hiramitsu S et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299–302.
12. Nery PB, Keren A, Healey J et al. Isolated cardiac sarcoidosis: Establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. Can J Cardiol 2013; 29: 1015e1–3.
13. Liang JJ, Hebl VB, DeSimone CV et al. Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis. JACC Heart Fail 2014; 2: 466–73.
14. Lehtonen JY, Jokinen JJ, Holmström M et al. Open-chest core needle biopsy of the left ventricle in the evaluation of suspected focal myocardial inflammation. J Thorac Cardiovasc Surg 2015; 149: e99–102.
15. Hamzeh N, Steckman DA, Sauer WH et al. Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol 2015; 12: 278–88.
16. Osborne MT, Hulten EA, Singh A et al. Reduction of 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol 2014; 21: 166–74.
17. Kandolin R, Lehtonen J, Airaksinen J et al. Usefulness of cardiac troponins as markers of early treatment response in cardiac sarcoidosis. Am J Cardiol 2015; 116: 960–6.
18. Okura Y, Dec GW, Hare JM et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 2003; 41: 322–9.
19. Yazaki Y, Isobe M, Hiroe M et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006–11.